About James Gale
James Gale is a managing director at Ascendia Pharmaceuticals.
Form D filings also name James Gale as a director at Pharmaceutics International.
James Gale reports to the SEC as a director or major shareholder of 6 public companies, including Teligent (TLGT), Pfenex (PFNX) and Bioject Medical Technologies (BJCT).
James Gale first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name James Gale in the role, so the role may have started earlier or lasted longer.
Ascendia Pharmaceuticals, Inc.
Managing Director
2022 – 2026 · North Brunswick, NJ
Ascendia helps drug developers formulate, test, and manufacture difficult products from discovery through commercialization.
TI
Teligent, Inc.
Director and 10% owner
2009 – 2020 · Public company (TLGT)
PI
Pfenex Inc.
Director
2014 – 2015 · Public company (PFNX)
BI
Bioject Medical Technologies Inc.
Director
2006 – 2014 · Public company (BJCT)
EI
Endo Pharmaceuticals Solutions Inc.
Director
2007 – 2009 · Public company (IDEV)
VI
Valera Pharmaceuticals Inc
Director and 10% owner
2006 – 2007 · Public company (VLRX)
BC
BK Technologies Corp
Director
2006 · Public company (BKTI)
Key Colleagues at Startups
The people James Gale works with at each company, as listed on that company's latest Form D.
Ascendia Pharmaceuticals, Inc. · Form D/A, Nov 6, 2026
JH
Jingjun Huang
CEO and director
MB
Michael Bogda
Executive officer and director
RB
Robert Bloder
Chief Commercial Officer and director
Theron Odlaug
Director
SL
Shoufeng Li
Director
TD
Todd Daviau
Executive officer
Pharmaceutics International, Inc. · Form D/A, Oct 23, 2024
DS
David Solomon
Director
MK
Mark Kavulich
Director
SD
Syed Abidi, Ph.D.
Director
JF
John Fowler
Executive officer and director
MB
Michael Bogda
Director